NCT05033327 is a NA clinical trial of Nutrition and Exercise app in Cirrhosis, Liver, sponsored by University of Alberta.

Who is sponsoring NCT05033327?

NCT05033327 is sponsored by University of Alberta.

What drugs are being tested in NCT05033327?

Interventions in NCT05033327: Nutrition and Exercise app.

What condition does NCT05033327 study?

NCT05033327 studies Cirrhosis, Liver, Hepatic Encephalopathy.

Is NCT05033327 still recruiting?

NCT05033327 is currently completed. Last updated 1 February 2023.

Last reviewed 2023-02-01 · How we verify

NCT05033327

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis

Completed NA Last updated 1 February 2023

What this trial tests

NA trial testing Nutrition and Exercise app in Cirrhosis, Liver in 27 participants. Completed in 31 December 2022.

Timeline

20 April 2021

Primary endpoint
31 March 2022

31 December 2022

Quick facts

Lead sponsor	University of Alberta
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	27
Start date	20 April 2021
Primary completion	31 March 2022
Estimated completion	31 December 2022
Sites	1 location across Canada

Drugs / interventions tested

Nutrition and Exercise app

Conditions studied

Cirrhosis, Liver — all drugs for Cirrhosis, Liver →
Hepatic Encephalopathy — all drugs for Hepatic Encephalopathy →

Sponsor

University of Alberta

Who can join

18 and older, any sex, with Cirrhosis, Liver or Hepatic Encephalopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The personalized nutrition and exercise app was designed for use by individuals living with chronic conditions. The pilot study examines the acceptance and use of the online, interactive program to support self-management in cirrhosis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

An open label feasibility study of a nutrition and exercise app-based solution in cirrhosis.
Ismond KP, Cruz C, Limon-Miro AT, Low G, et al · · 2024 · cited 3× · PMID 38505789 · DOI 10.3138/canlivj-2023-0011
Initial participant perspectives about participating in an online, semi-supervised, cirrhosis-specific nutrition and exercise intervention.
Ismond KP, McNeely ML, Spence JC, Spiers JA, et al · · 2025 · cited 1× · PMID 39624948 · DOI 10.1111/bjhp.12769

Verify or expand the search:

Other recruiting trials for Cirrhosis, Liver

Currently open trials in the same condition.

NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
NCT07051369 — Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound · active not recruiting
NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting

Other University of Alberta trials

Trials by the same sponsor.

NCT03240900 — Electrical Stimulation for Improving Postoperative Breast Sensation · NA · not yet recruiting
NCT04231760 — The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD · Phase 1, PHASE2 · not yet recruiting
NCT06649604 — Reducing Pain From Retinal Laser With Vibrational Stimulation · NA · not yet recruiting
NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT06920914 — Effects of Minimally vs. Ultra-Processed Diets on Potassium (K) Handling in CKD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05033327 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alberta
Last refreshed: 1 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05033327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing